```markdown
# QUEtiapine
## 977

### Gotu kola, kava kava, St. John's wort, valerian may increase CNS depression. FOOD: None known. LAB VALUES: May decrease total free thyroxine (T4) serum levels. May increase serum cholesterol, triglycerides, ALT, AST, WBC, GGT. May produce false-positive pregnancy test result.

## AVAILABILITY (Rx)
- **Tablets:** 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg
- **Tablets, Extended-Release:** 50 mg, 150 mg, 200 mg, 300 mg, 400 mg

## ADMINISTRATION/HANDLING
- **PO:** Give immediate-release tablets without regard to food. Do not break, crush, dissolve, or divide extended-release tablets. Extended-release tablets should be given without regard to food or with a light meal in evening.

## INDICATIONS/ROUTES/DOSAGE
- **Note:** When restarting pts who have been off QUEtiapine for less than 1 wk, titration is not required and maintenance dose can be reinstituted. When restarting pts who have been off QUEtiapine for longer than 1 wk, follow initial titration schedule. When discontinuing, gradual tapering recommended to avoid withdrawal symptoms and minimize risk of relapse.

### Mania (in Bipolar Disorder)
- **PO:** _(Immediate-Release):_ ADULTS, ELDERLY: Initially, 50 mg twice daily for 1 day. May increase in increments of 100 mg/day to 200 mg twice daily on day 4. May further increase in increments of 200 mg/day on day 6. Range: 400–800 mg/day _(Extended-Release):_ Initially, 300 mg on day 1 in the evening; 600 mg on day 2 and adjust between 400–800 mg/day thereafter. _(Immediate-Release):_ CHILDREN 10 YRS AND OLDER: 25 mg twice daily on day 1, 50 mg twice daily on day 2, then increase by 100 mg/day until target dose of 400 mg/day reached on day 5. May increase up to 600 mg/day. Range: 400–600 mg/day _(Extended-Release):_ CHILDREN 10 YRS AND OLDER: 50 mg on day 1; 100 mg on day 2; further increase of 100 mg/day until 400 mg once daily is reached on day 4. Usual range: 400–600 mg once daily.

### Schizophrenia
- **PO:** _(Immediate-Release):_ ADULTS, ELDERLY: Initially 25 mg twice daily, then increase in 25–50-mg increments divided 2–3 times/day on the second and third days, up to 300–400 mg/day in 2–3 divided doses of the fourth twice. Further adjustments of 25–50 mg/day may be made at intervals of 2 days or longer. Maintenance: 150–750 mg/day (adults); 50–200 mg/day (elderly). _(Extended-Release):_ Initially, 300 mg/day. May increase at intervals of 1 day up to 300 mg/day. Range: 400–800 mg/day. _(Immediate-Release):_ CHILDREN

### Depression in Bipolar Disorder
- **PO:** _(Immediate-Release):_ ADULTS, ELDERLY: 50 mg/day on day 1, increase to 100 mg/day on day 2, then increase by 100 mg/day up to target dose of 300 mg/day _(Extended-Release):_ Initially, 50 mg on day 1 in the evening; 100 mg on day 2, 200 mg on day 3, 300 mg on day 4 and thereafter.

### Adjunctive Therapy in MDD
- **PO:** ADULTS, ELDERLY: _(Extended-Release):_ Initially, 50 mg on days 1 and 2; then 150 mg on days 3 and 4; then 150–300 mg/day thereafter.

| Canadian trade name | Non-Crushable Drug | High Alert drug |
```